Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 57604 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 74177 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 77927 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 85012 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 89311 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 89788 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 91491 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 93308 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 94161 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 94972 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 95922 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 97438 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 98532 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 98578 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 98736 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 99619 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 99773 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 99850 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 99912 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 100234 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 100236 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 100477 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 100508 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 101023 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 102111 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 102170 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 102434 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 102561 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 102614 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 103564 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 103678 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 104107 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 104202 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 104925 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 104997 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 105243 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 105324 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 105450 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 105528 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 105700 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 105951 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 106050 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 106507 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 106609 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 106697 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107015 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107044 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107090 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107186 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107428 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107446 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107601 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107716 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107768 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107860 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 107909 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108000 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108257 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108293 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108355 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108432 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108599 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108906 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 108915 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 109234 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 109958 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 109973 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 110291 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 110307 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 110462 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 110510 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 110602 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 110785 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 111050 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 111057 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 111218 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 111674 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 111970 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112031 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112073 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112244 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112264 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112296 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112317 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112340 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112440 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112519 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112677 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112794 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112896 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 112930 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 113188 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 113450 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 113488 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 113814 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114141 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114157 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114256 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114319 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114355 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114454 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 114503 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115003 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115132 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115318 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115393 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115415 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115558 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115810 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 115979 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116028 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116044 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116142 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116216 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116381 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116557 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116575 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116579 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 116943 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 117076 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 117120 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 117339 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 117477 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 117564 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 117860 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 118089 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 118091 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 118366 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 118782 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 118805 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119107 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119230 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119263 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119406 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119439 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119464 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119902 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 119928 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 120042 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 120151 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 120323 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 120394 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 120860 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 120904 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121017 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121108 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121188 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121349 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121357 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121694 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121699 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 121730 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 122167 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 122254 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 122325 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 122401 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 122457 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 122611 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123140 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123323 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123349 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123462 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123599 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123778 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123816 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123847 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123850 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 123864 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 124186 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 124488 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 124743 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 124765 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 124780 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 124965 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 125387 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 125622 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 125641 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 126249 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 126511 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 126872 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 127218 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 127393 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 127674 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 127819 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 127887 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 128305 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 128341 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 128998 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 129220 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 129355 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 129491 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 129812 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 130888 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 131325 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 131344 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 131538 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 131585 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 131772 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 131999 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 133282 | Peak area normalized | No | PAH | Female | Cath |
Return to search page